M. Tohen

477 total citations
17 papers, 397 citations indexed

About

M. Tohen is a scholar working on Psychiatry and Mental health, Pharmacology and Social Psychology. According to data from OpenAlex, M. Tohen has authored 17 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 2 papers in Pharmacology and 2 papers in Social Psychology. Recurrent topics in M. Tohen's work include Bipolar Disorder and Treatment (9 papers), Schizophrenia research and treatment (4 papers) and Electroconvulsive Therapy Studies (3 papers). M. Tohen is often cited by papers focused on Bipolar Disorder and Treatment (9 papers), Schizophrenia research and treatment (4 papers) and Electroconvulsive Therapy Studies (3 papers). M. Tohen collaborates with scholars based in United States and Germany. M. Tohen's co-authors include Daniel C. Goodwin, P. Mayer, Andrej Stoll, S M Strakowski, Gianni L. Faedda, Deborah Yurgelun‐Todd, Perry F. Renshaw, Staci A. Gruber, B.M. Cohen and Shelly F. Greenfield and has published in prestigious journals such as American Journal of Psychiatry, Schizophrenia Research and Bipolar Disorders.

In The Last Decade

M. Tohen

15 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Tohen United States	9	287	143	71	54	50	17	397
Sara Lucas Australia	13	353 1.2×	106 0.7×	115 1.6×	27 0.5×	125 2.5×	18	484
Leonardo Cortese Canada	11	343 1.2×	125 0.9×	94 1.3×	14 0.3×	59 1.2×	13	424
Katia De Santi Italy	12	195 0.7×	121 0.8×	36 0.5×	22 0.4×	43 0.9×	20	322
Lasse Randers Denmark	12	315 1.1×	152 1.1×	103 1.5×	59 1.1×	100 2.0×	14	453
Stanley Mutsatsa United Kingdom	9	466 1.6×	143 1.0×	142 2.0×	24 0.4×	128 2.6×	16	581
Norman A. Todd United Kingdom	8	326 1.1×	173 1.2×	94 1.3×	28 0.5×	37 0.7×	12	390
Martin Osugo United Kingdom	8	150 0.5×	74 0.5×	54 0.8×	42 0.8×	92 1.8×	18	300
T.R.E. Barnes United Kingdom	6	287 1.0×	75 0.5×	60 0.8×	8 0.1×	67 1.3×	18	402
Geneviève Létourneau Canada	10	125 0.4×	120 0.8×	38 0.5×	19 0.4×	50 1.0×	19	299
Graham Bean Canada	12	201 0.7×	176 1.2×	95 1.3×	21 0.4×	89 1.8×	17	471

Countries citing papers authored by M. Tohen

Since Specialization

Citations

This map shows the geographic impact of M. Tohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Tohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Tohen more than expected).

Fields of papers citing papers by M. Tohen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Tohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Tohen. The network helps show where M. Tohen may publish in the future.

Co-authorship network of co-authors of M. Tohen

This figure shows the co-authorship network connecting the top 25 collaborators of M. Tohen. A scholar is included among the top collaborators of M. Tohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Tohen. M. Tohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Katagiri, Hideki, et al.. (2013). P.2.d.016 Efficacy of olanzapine monotherapy in the treatment of bipolar depression with varying degrees of manic symptoms. European Neuropsychopharmacology. 23. S372–S372.

Pacchiarotti, Isabella, Adriane Ribeiro Rosa, Lorenzo Mazzarini, et al.. (2009). P.2.e.00l Predominant polarity as an outcome predictor in a clinical trial for bipolar depression. European Neuropsychopharmacology. 19. S448–S449. 1 indexed citations

Robertson-Plouch, Carol, et al.. (2007). Olanzapine versus placebo in adolescents with schizophrenia. Pharmacopsychiatry. 40(5). 2 indexed citations

Renshaw, Perry F., et al.. (2003). Olanzapine induced reductions in frontal lobe lactate levels correlate with treatment response in first episode psychosis. Schizophrenia Research. 60(1). 301–301. 4 indexed citations

Vieta, Eduard, M. Tohen, Terence A. Ketter, et al.. (2003). P.1.078 Long-term use of olanzapine or olanzapine/fluoxetine for bipolar depression. European Neuropsychopharmacology. 13. S207–S208. 1 indexed citations

Evans, Angela R., M. Tohen, Andreas Marneros, et al.. (2003). P.1.092 Olanzapine versus lithium in relapse prevention in bipolar disorder: A randomized double-blind controlled 12-month clinical trial. European Neuropsychopharmacology. 13. S213–S213. 21 indexed citations

Woods, Scott W., Alan Breier, R.B. Zipursky, et al.. (2003). Olanzapine versus placebo for prodromal symptoms. Schizophrenia Research. 60(1). 306–307. 6 indexed citations

Tohen, M., C.L. Bowden, Joseph D. Calabrese, et al.. (2003). P.1.091 Olanzapine's efficacy for relapse prevention in bipolar disorder: A randomized double-blind placebo-controlled 12-month clinical trial. European Neuropsychopharmacology. 13. S212–S213. 16 indexed citations

Baker, Robert W., Joseph F. Goldberg, M. Tohen, et al.. (2002). The impact of response to previous mood stabilizer therapy on response to olanzapine versus placebo for acute mania. Bipolar Disorders. 4(1). 43–49. 13 indexed citations

10.

Tohen, M., et al.. (2002). Olanzapine combined with mood stabilizers in prevention of recurrence in bipolar disorder: An 18-month study. European Neuropsychopharmacology. 12. 307–307. 9 indexed citations

11.

Tohen, M., Eduard Vieta, Joseph D. Calabrese, et al.. (2002). Olanzapine in the treatment of bipolar depression. European Neuropsychopharmacology. 12. 238–239. 10 indexed citations

12.

Tohen, M., T. Jacobs, V. Toma, et al.. (2000). Is olanzapine a mood-stabilizer?. Schizophrenia Research. 41(1). 193–194. 6 indexed citations

13.

Tohen, M., et al.. (1999). Olanzapine in the treatment of mania: A placebo-controlled four-week study. European Neuropsychopharmacology. 9. 247–247. 4 indexed citations

14.

Greenfield, Shelly F., Roger D. Weiss, & M. Tohen. (1995). Substance abuse and the chronically mentally ill: A description of dual diagnosis treatment services in a psychiatric hospital. Community Mental Health Journal. 31(3). 265–277. 35 indexed citations

15.

Renshaw, Perry F., Deborah Yurgelun‐Todd, M. Tohen, Staci A. Gruber, & B.M. Cohen. (1995). Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis. American Journal of Psychiatry. 152(3). 444–446. 75 indexed citations

16.

Strakowski, S M, M. Tohen, Andrej Stoll, et al.. (1993). Comorbidity in psychosis at first hospitalization. American Journal of Psychiatry. 150(5). 752–757. 134 indexed citations

17.

Pope, Harrison G., et al.. (1985). An empirical study of psychosis in borderline personality disorder. American Journal of Psychiatry. 142(11). 1285–1290. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact